Anixa Biosciences 035229BQ5 Bond

ANIX Stock  USD 3.30  0.01  0.30%   
Anixa Biosciences holds a debt-to-equity ratio of 0.007. At this time, Anixa Biosciences' Debt To Equity is fairly stable compared to the past year. Debt Equity Ratio is likely to rise to 0 in 2024, whereas Net Debt is likely to drop (699.3 K) in 2024. With a high degree of financial leverage come high-interest payments, which usually reduce Anixa Biosciences' Earnings Per Share (EPS).

Asset vs Debt

Equity vs Debt

Anixa Biosciences' liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. Anixa Biosciences' cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps Anixa Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect Anixa Biosciences' stakeholders.
For most companies, including Anixa Biosciences, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for Anixa Biosciences, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, Anixa Biosciences' management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Price Book
4.8925
Book Value
0.677
Return On Assets
(0.35)
Return On Equity
(0.55)
At this time, Anixa Biosciences' Total Current Liabilities is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to rise to about 30.8 M in 2024, whereas Non Current Liabilities Total is likely to drop slightly above 134.4 K in 2024.
  
Check out the analysis of Anixa Biosciences Fundamentals Over Time.
For more information on how to buy Anixa Stock please use our How to Invest in Anixa Biosciences guide.
View Bond Profile
Given the importance of Anixa Biosciences' capital structure, the first step in the capital decision process is for the management of Anixa Biosciences to decide how much external capital it will need to raise to operate in a sustainable way. Once the amount of financing is determined, management needs to examine the financial markets to determine the terms in which the company can boost capital. This move is crucial to the process because the market environment may reduce the ability of Anixa Biosciences to issue bonds at a reasonable cost.
Popular NameAnixa Biosciences US035229BQ59
SpecializationPharmaceuticals, Biotechnology & Life Sciences
Equity ISIN CodeUS03528H1095
Bond Issue ISIN CodeUS035229BQ59
S&P Rating
Others
Maturity DateOthers
Issuance DateOthers
Coupon6.5 %
View All Anixa Biosciences Outstanding Bonds

Anixa Biosciences Outstanding Bond Obligations

Dana 575 percentUS235822AB96Details
Volcan Compania MineraUSP98047AC08Details
Boeing Co 2196US097023DG73Details
ANHEUSER BUSCH INBEV FINUS035242AN64Details
ANHEUSER BUSCH INBEV FINUS035242AM81Details
HSBC Holdings PLCUS404280DR76Details
ANHEUSER BUSCH INBEV FINUS035242AB27Details
US035229BP76US035229BP76Details
US035229BQ59US035229BQ59Details
ANHEUSER BUSCH PANIES LLCUS03522AAJ97Details
ANHEUSER BUSCH LLC ANHEUSER US03522AAG58Details
ANHEUSER BUSCH PANIES LLCUS03522AAH32Details
ANHEUSER BUSCH INBEVUS03524BAF31Details
MPLX LP 52US55336VAL45Details
ANHEUSER BUSCH INCUS035229CQ41Details
US035229DA89US035229DA89Details
US035229CG68US035229CG68Details
ABIBB 68 20 AUG 32US035229CJ08Details
International Game TechnologyUS460599AD57Details
ANHEUSER BUSCH INCUS035229DC46Details
US03523TAP30US03523TAP30Details
ANHEUSER BUSCH INBEVUS03523TBW71Details
ANHEUSER BUSCH INBEVUS03523TBV98Details
ANHEUSER BUSCH INBEVUS03523TBU16Details
ANHEUSER BUSCH INBEVUS03523TBT43Details
ANHEUSER BUSCH INBEVUS03523TBQ04Details
ANHEUSER BUSCH INBEV WORLDWIDEUS035240AV25Details
ANHEUSER BUSCH INBEV WORLDWIDEUS035240AU42Details
ANHEUSER BUSCH INBEV WORLDWIDEUS035240AS95Details
ANHEUSER BUSCH INBEV WORLDWIDEUS035240AT78Details
ANHEUSER BUSCH INBEV WORLDWIDEUS035240AG57Details
Morgan Stanley 3591US61744YAK47Details
ANHEUSER BUSCH INBEV WORLDWIDEUS035240AQ30Details
ANHEUSER BUSCH INBEV WORLDWIDEUS035240AR13Details
ANHEUSER BUSCH INBEV WORLDWIDEUS035240AP56Details
ANHEUSER BUSCH INBEV WORLDWIDEUS035240AN09Details
ANHEUSER BUSCH INBEV WORLDWIDEUS035240AM26Details
ANHEUSER BUSCH INBEV WORLDWIDEUS035240AL43Details
MGM Resorts InternationalUS552953CD18Details

Understaning Anixa Biosciences Use of Financial Leverage

Understanding the structure of Anixa Biosciences' debt obligations provides insight if it is worth investing in it. Financial leverage can amplify the potential profits to Anixa Biosciences' owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if the firm cannot cover its cost of debt.
Last ReportedProjected for Next Year
Net Debt-666 K-699.3 K
Short and Long Term Debt Total157.5 K149.6 K
Long Term Debt Total630.9 K319.5 K
Short Term Debt46.8 K44.5 K
Net Debt To EBITDA 0.08  0.07 
Interest Debt Per Share 0.01  0.01 
Long Term Debt To Capitalization 2.24  1.21 
Cash Flow To Debt Ratio(162.30)(154.18)
Please read more on our technical analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Anixa Stock Analysis

When running Anixa Biosciences' price analysis, check to measure Anixa Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Anixa Biosciences is operating at the current time. Most of Anixa Biosciences' value examination focuses on studying past and present price action to predict the probability of Anixa Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Anixa Biosciences' price. Additionally, you may evaluate how the addition of Anixa Biosciences to your portfolios can decrease your overall portfolio volatility.

What is Financial Leverage?

Financial leverage is the use of borrowed money (debt) to finance the purchase of assets with the expectation that the income or capital gain from the new asset will exceed the cost of borrowing. In most cases, the debt provider will limit how much risk it is ready to take and indicate a limit on the extent of the leverage it will allow. In the case of asset-backed lending, the financial provider uses the assets as collateral until the borrower repays the loan. In the case of a cash flow loan, the general creditworthiness of the company is used to back the loan. The concept of leverage is common in the business world. It is mostly used to boost the returns on equity capital of a company, especially when the business is unable to increase its operating efficiency and returns on total investment. Because earnings on borrowing are higher than the interest payable on debt, the company's total earnings will increase, ultimately boosting stockholders' profits.

Leverage and Capital Costs

The debt to equity ratio plays a role in the working average cost of capital (WACC). The overall interest on debt represents the break-even point that must be obtained to profitability in a given venture. Thus, WACC is essentially the average interest an organization owes on the capital it has borrowed for leverage. Let's say equity represents 60% of borrowed capital, and debt is 40%. This results in a financial leverage calculation of 40/60, or 0.6667. The organization owes 10% on all equity and 5% on all debt. That means that the weighted average cost of capital is (.4)(5) + (.6)(10) - or 8%. For every $10,000 borrowed, this organization will owe $800 in interest. Profit must be higher than 8% on the project to offset the cost of interest and justify this leverage.

Benefits of Financial Leverage

Leverage provides the following benefits for companies:
  • Leverage is an essential tool a company's management can use to make the best financing and investment decisions.
  • It provides a variety of financing sources by which the firm can achieve its target earnings.
  • Leverage is also an essential technique in investing as it helps companies set a threshold for the expansion of business operations. For example, it can be used to recommend restrictions on business expansion once the projected return on additional investment is lower than the cost of debt.
By borrowing funds, the firm incurs a debt that must be paid. But, this debt is paid in small installments over a relatively long period of time. This frees funds for more immediate use in the stock market. For example, suppose a company can afford a new factory but will be left with negligible free cash. In that case, it may be better to finance the factory and spend the cash on hand on inputs, labor, or even hold a significant portion as a reserve against unforeseen circumstances.

The Risk of Financial Leverage

The most obvious and apparent risk of leverage is that if price changes unexpectedly, the leveraged position can lead to severe losses. For example, imagine a hedge fund seeded by $50 worth of investor money. The hedge fund borrows another $50 and buys an asset worth $100, leading to a leverage ratio of 2:1. For the investor, this is neither good nor bad -- until the asset price changes. If the asset price goes up 10 percent, the investor earns $10 on $50 of capital, a net gain of 20 percent, and is very pleased with the increased gains from the leverage. However, if the asset price crashes unexpectedly, say by 30 percent, the investor loses $30 on $50 of capital, suffering a 60 percent loss. In other words, the effect of leverage is to increase the volatility of returns and increase the effects of a price change on the asset to the bottom line while increasing the chance for profit as well.